Katja Seipel

32PUBLICATIONS

19CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyHaematological tumoursImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jul 15, 2026

Clinical Impact of a Germline CD19 Variant on Treatment Outcome After CAR-T Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma.

|Jul 15, 2026

Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma.

|Jun 26, 2026

Influence of PPM1D Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients.

|Jun 12, 2026

Prophylactic Anakinra to Prevent Neurotoxicity After CAR T-Cell Therapy in Aggressive B-Cell Lymphomas: A Single-Center Real-World Experience.

|Jun 12, 2026

Clinical Impact of the CTLA4 rs231775 Polymorphism in Acute Myeloid Leukemia Treated with Autologous Stem Cell Transplantation.

|May 27, 2026

Elevated Allele Frequency of a Common Germline LAG3 Variant Associated with Anemia, Thrombocytopenia and Peripheral Blast Percentage in Acute Myeloid Leukemia.

Pageof 6

Frequent Collaborators

32 joint publications

Vera Ulrike Bacher

29 joint publications

Thomas Pabst

Henning Nilius

Martina Bertschinger

Dilara Akhoundova

Michael Daskalakis

Gertrud Wiedemann

Naomi Porret

Jeffrey R Idle

Katharina van der Weg

Frequent Collaborators

32 joint publications

Vera Ulrike Bacher

29 joint publications

Thomas Pabst

9 joint publications

Henning Nilius

6 joint publications

Martina Bertschinger